Population‐based studies found that higher NPY levels were correlated with a greater risk of hospitalization, heart transplantation and ventricular assist device placement in patients with heart failure, and were associated with cardiovascular events and all‐cause death even after adjustment for other prognostic variables [5, 31]. This evidence concerns the gene NPY and heart failure.